Aptevo Therapeutics Inc (NASDAQ:APVO) currently has a daily average trading volume of 65.64K but it saw 22969111 shares traded in last market. With a market cap of 2.02M USD, the company’s current market price of $1.38 came rising about 38.26 while comparing to the previous closing price of $1.00. In past 52 weeks, the stock remained buoying in the range of price level as high as $180.19 and as low as $0.94. In the recent trading on the day, stock has struck highest price mark of $1.0 while lowest mark touched by it was $3.61.
Taking a look at 20-day trading activity of Aptevo Therapeutics Inc (APVO) gives us an average price of $2.1044, while its current price level is -99.23% below from 52-week high level whereas it is 46.45% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.1392 while that of 200 days or SMA-200 reads an average of $8.7153. A closer look into the stock’s movement over the week reveals that its volatility is standing at 68.15% during that period while stretching the period over a month that decreases to 24.73%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 31.10 which implies that the stock is in neutral territory.
Over the week, APVO’s stock price is moving -10.39% down while it is -53.22% when we observe its performance for the past one month. Year-to-date it is -67.98% down and over the past year, the stock is showing a downside performance of -99.12%.
The company is expected to be releasing its next quarterly report on 2025-Feb-13, for which analysts forecasted an EPS of -4.21 while estimate for next year EPS is -15.84.
Currently, Aptevo Therapeutics Inc’s total number of outstanding shares is 1.46M with 0.01% of that held by the insiders while 4.85% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -257.14% and return on equity (ROE) at -284.28%. Stock’s beta reads 6.00. Stock has a price to book (P/B) ratio of 0.42. Its return on asset (ROA) is -119.36% on average.
